To hear about similar clinical trials, please enter your email below
Trial Title:
The Effect of Foot Massage With Roles on Cancer Patients
NCT ID:
NCT06376357
Condition:
Breast Neoplasms
Over Cancer
Foot Massage
Conditions: Official terms:
Breast Neoplasms
Study type:
Interventional
Study phase:
N/A
Overall status:
Enrolling by invitation
Study design:
Allocation:
Randomized
Intervention model:
Parallel Assignment
Primary purpose:
Supportive Care
Masking:
Single (Investigator)
Intervention:
Intervention type:
Other
Intervention name:
Foot Massage with roller
Description:
The intervention group is expected to apply roller massage to the soles of both feet in a
sitting position on a chair (8 hours apart at 08.00, 16.00, 24.00 hours) every day for 6
weeks, 3x5 minutes a day. Video recording will be used as a reminder in the application.
Arm group label:
Study
Summary:
It was aimed to examine the roles in the management of treatment-related peripheral
neuropathy in cancer patients receiving taxane-based chemotherapy and the effect of foot
massage on neuropathy and quality of life.
Detailed description:
Intervention Phase of the Research;
1. Patient information about neuropathy caused by chemotherapy and its management,
2. Teaching the role application to the patient,
3. Application process
4. It will be carried out in 4 steps, including patient monitoring via telemonitoring.
Criteria for eligibility:
Criteria:
Inclusion Criteria:
- Being registered in the medical oncology outpatient clinic of Selçuk University
Faculty of Medicine Hospital
- Completed standard taxane-based chemotherapy treatment protocol for breast and
ovarian cancer
- Karnofsky Performance Scale being 80 and above (Performance scale of cancer
patients)
- Being 18 years or older
- Having received at least 3 cycles of taxane-based treatment
- Presence of grade 2 or higher peripheral neuropathy
- Being conscious and cooperative
- Verbal and written approval to participate in the study after an explanation about
the study is made.
Exclusion Criteria:
- Previous skin sensitivity on hands and feet
- Refused to participate in the study after making a statement about the study
- Development of peripheral neuropathy due to reasons other than chemotherapy [tumor
compression, nutritional disorders, infections or major systemic disease (diabetes
mellitus, etc.)]
- Bone, spine metastasis or malignancy
- Having mental and psychic problems that would prevent him from taking part in the
research.
Gender:
Female
Minimum age:
18 Years
Maximum age:
65 Years
Healthy volunteers:
No
Locations:
Facility:
Name:
ülkü Saygili Düzova
Address:
City:
Selçuklu
Country:
Turkey
Start date:
April 27, 2024
Completion date:
July 30, 2024
Lead sponsor:
Agency:
Selcuk University
Agency class:
Other
Source:
Selcuk University
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT06376357
